Immunology, tumor markers, and pancreatic cancer.
D000230:Adenocarcinoma / Q000276:immunology; D000888:Antibodies, Anti-Idiotypic; D000951:Antigens, Neoplasm; D001789:Blood Group Antigens; D001826:Body Fluids / Q000276:immunology; D002272:Carcinoembryonic Antigen / Q000032:analysis; D004386:Duodenum; D005260:Female; D005333:Fetus / Q000276:immunology; D006023:Glycoproteins / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D007519:Isoantigens; D007527:Isoenzymes / Q000276:immunology; D008099:Liver / Q000276:immunology / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010189:Pancreatic Juice / Q000276:immunology; D010190:Pancreatic Neoplasms / Q000097:blood / Q000188:drug therapy / Q000276:immunology*; D010455:Peptides / Q000276:immunology; D010920:Placenta / Q000201:enzymology / Q000276:immunology; D011247:Pregnancy; D000509:alpha-Fetoproteins / Q000276:immunology
D000888:Antibodies, Anti-Idiotypic; D000951:Antigens, Neoplasm; D001789:Blood Group Antigens; D002272:Carcinoembryonic Antigen; D006023:Glycoproteins; D007519:Isoantigens; D007527:Isoenzymes; D010455:Peptides; D000509:alpha-Fetoproteins